Proof-of-concept research points to wearable monitors’ potential to offer low-cost, non-invasive way to detect this dangerous bone-marrow transplant complication.
Demsky joined the University of Michigan Rogel Cancer Center communications team in 2019. Prior to that he served as director of communications for the University of Michigan's Life Sciences Institute and science editor for Medicine at Michigan Magazine.
An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.
A potent and selective degrader of the transcription factor STAT3 offers a new approach to a previously “undruggable” target.
Looking beyond DNA mutations to a combination of molecular features could help determine the best drug combinations for each patient.
As the opioid crisis unfolded, prescriptions for the narcotic alternative saw a two-fold increase despite unclear evidence of benefit for pain.